SUBSCRIBE
SUBSCRIBE
News   Drug Development

NeoPharm To Present LErafAON-ETU Preliminary Phase I Data At AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics

November 8, 2005 | 
1 min read
BIOWIRE2K AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. WAUKEGAN, Ill.--(BUSINESS WIRE)--Nov. 8, 2005--NeoPharm, Inc. (Nasdaq/NM:NEOL): Who/What: NeoPharm, Inc. (Nasdaq/NM:NEOL) LErafAON-ETU poster presentation.
Clinical research Phase I
MORE ON THIS TOPIC
Brain shaped maze. Concept image of study and brain behavior.
Parkinson’s disease
Ventyx’s Parkinson’s Pill Shows ‘Promising’ Results in Mid-Stage Study, Paving Path to Other Neuro Diseases
June 17, 2025
 · 
2 min read
 · 
Tristan Manalac
vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Cancer
Roche, AbbVie’s Venclexta Stumbles Again, This Time in Myelodysplastic Syndromes
June 17, 2025
 · 
1 min read
 · 
Tristan Manalac
Climb up, hand help businessman build ladder
Weight loss
Lilly Notches ‘Top-Tier’ Weight Loss Results for Phase I Amylin/Tirzepatide Combo
June 16, 2025
 · 
2 min read
 · 
Annalee Armstrong
Working man icon pushing the load on the line. Hard work, labor, effort and determination concept.
Parkinson’s disease
Roche, Prothena Push Parkinson’s Drug to Phase III Despite Mid-Stage Fail
June 16, 2025
 · 
2 min read
 · 
Tristan Manalac